课题基金 / 基金详情

The Research and Development of Gene Therapy for Breast Cancer by Src Signal Tiansduction Pathways

The Research and Development of Gene Therapy for Breast Cancer by Src Signal Tiansduction Pathways
Src信号天诱导通路乳腺癌基因治疗的研究进展
批准号:
15591337
负责人:
ODA Koji
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

ODA Koji的其他基金

相似基金

相关文献

中文摘要
翻译
背景:SRC Homology 2结构域蛋白酪氨酸磷酸酶底物-1(SHPS-1 TS,又称P84、BIT、SIRP)是一种参与受体酪氨酸激酶信号转导的异嗜性粘附膜蛋白,广泛表达于哺乳动物的中枢神经系统、免疫系统等组织中。SHPS-1的功能是控制细胞的迁移和扩散。我们研究了SHPS-1的细胞定位及其与包括预后在内的临床病理特征的关系。设计:采用免疫组织化学和Western blotting方法检测5个细胞系和63例乳腺癌标本中SHPS-1的表达和细胞定位。所用的单抗为SHPS-1(兔多克隆抗体,Neomarkers)。研究的临床病理因素包括年龄、分期、肿瘤类型、组织学分级和核分裂指数(MI)。用Kaplan-Meier方法评估总生存率和无病生存率。结果:通过Western blotting分析,在组织样本和细胞系中检测到100 kDa的蛋白。在正常粘膜上皮细胞中有膜性表达。乳腺癌中胞浆阳性(c+)22例(35%),阴性4例(65%),c(+)与c(-)在年龄、分期、类型等方面无明显差异。SHPS-1的表达与组织学分级有显著相关性:c+21例(95%)为G2-G3级(P<0.05)。C(+)组MI(1.86±1.6)显著高于C(-)组(0.71±0.56)。C(+)患者的总体生存率和无病生存率均低于c(-)患者(P=0.044和P=0.015)。结论:SHPS-1胞浆表达可能与基因突变有关。SHPS-1可能是基因治疗的合理候选者。
英文摘要
Background : Src homology 2 domain-containing protein tyrosine phosphatase(SHP) substrate-1(SHPS-1 TS also known as p84,BIT, and SIRP) is a heterophilic adhesive membrane protein involved in receptor tyrosine kinase signaling that is expressed widely in the mammalian central nervous system, immune system and other tissues. The function of SHPS-1 is to control cell migration and spreading.We studied the SHPS-1 cellular localization and its significance in relation to clinicopathological features including prognosis.Design : Five cell lines and 63 specimens of breast carcinomas were examined to evaluate SHPS-1 expression and cellular localization by immunohistochemistry and western blotting. The monoclonal antibodies used was SHPS-1 (rabbit polyclonal antibody, Neomarkers). The clinicopathological factors studied were age, staging, tumor type, histological grade and mitotic index(MI). Overall survival and diseases-free survival were evaluated using the Kaplan-Meier method.Result : We detected 100-kDa proteins in tissue samples and cell lines by Western blotting analysis. In normal epithelium, there was a membranous expression. In breast carcinomas, 22 cases (35%) showed cytoplasmic positivity (c+), whereas 4 leases (65%) were negative (c-), There was no difference in age, staging, type between c(+) and c(-). There was a statistically significant correlation between SHPS-1 expression and histological grade : 21cases (95%) of c(+) were G2-G3 tumors (P<0.05). The MI for c(+) cases(1.86±1.6) was significantly higher than that for C(-)(0.71±0.56). The cases with c(+) had poor overall and diseases-free survival rates than c(-)(P=0.044 and P=0.015,respectively).Conclusion : It was suggested that cytoplasmic expression of SHPS-1 could be associated with gene mutation. SHPS-1 could be the logical candidate for gene therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of the new treatment that targeted mammary cancer stem cell
  • 批准号:
    18591436
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.38万
  • 财政年份:
    2006
  • 负责人:
    ODA Koji
  • 依托单位:
FUNCTIONAL ANALYSIS OF P73 GENE AND P51/P63 GENE IN HUMAN MAMMARY TISSUE AND MAMMARY CARCINOMA
  • 批准号:
    12671152
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.05万
  • 财政年份:
    2000
  • 负责人:
    ODA Koji
  • 依托单位:
海外基金